This site is intended for health professionals only

Off-label prescribing


For the first time, the GMC is proposing that doctors can prescribe a cheaper off-label alternative to a licensed medicine, as long as it is approved in authoritative clinical guidelines and is just as safe and effective for the patient.

Good practice in prescribing and managing medicines and devices puts forward new standards designed to make prescribing safer for patients and support doctors in managing medicines.

Patients buying prescriptions online would receive greater protection under the guidance, which would require doctors prescribing via websites to liaise with the patient’s GP, unless the patient objects.

Doctors are also being asked to raise and to respond constructively to concerns raised by colleagues and patients about adverse incidents and near-misses involving the use of medicines and medical devices.

Tough standards for doctors working in sports medicine are set out for the first time, including guidance which says doctors who suspect that athletes’ performance is improperly enhanced should raise concerns when it is in the public interest.

The consultation also reiterates that doctors should avoid prescribing for themselves and their families, and that controlled drugs should only be prescribed in an emergency, when lives or health are at serious risk.

Niall Dickson, the Chief Executive of the GMC said: “Between 1995 and 2009 the number of drugs prescribed by GPs tripled. It is vital that our guidance on prescribing and managing medicines is up to date and relevant for doctors working today.

“We want to hear the views of doctors, patients, carers and other health professionals about the difficult decisions doctors can face when prescribing and how doctors can help their patients better understand the information about the medicines they are taking.”

The consultation opens on 6 April 2011 and will run until 27 May 2011. Doctors, other health professionals and members of the public who are interested in sharing their views can take part in the consultation by visiting our website at

Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine